Skip to content
10-Q

Quarterly Report

Panacea Life Sciences Holdings, Inc. PLSH

0001493152-23-041041

← back to feed
Filed
Nov 14, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 1, 2023 17.65M sh
Shares Diluted Q3 2023 · Sep 30, 2023 16.62M sh
Shares Diluted Q3 2023 · Sep 30, 2023 16.62M sh
Shares Diluted Q3 2023 · Sep 30, 2022 14.86M sh
Shares Diluted Q3 2023 · Sep 30, 2022 14.86M sh
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$1.53M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$1.88M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $1.5K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $6.95K
Stockholders Equity Q3 2023 · Sep 30, 2023 −$6.08M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$5.57M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$2.14M
Stockholders Equity Q3 2023 · Sep 30, 2022 −$439.91K
Stockholders Equity Q3 2023 · Jun 30, 2022 $2.25M
Stockholders Equity Q3 2023 · Dec 31, 2021 $7.1M
Current Liabilities Q3 2023 · Sep 30, 2023 $18.54M
Current Liabilities Q3 2023 · Dec 31, 2022 $15.07M
Total Liabilities Q3 2023 · Sep 30, 2023 $24.82M
Total Liabilities Q3 2023 · Dec 31, 2022 $21.63M
Current Assets Q3 2023 · Sep 30, 2023 $5.87M
Current Assets Q3 2023 · Dec 31, 2022 $6.38M
Total Assets Q3 2023 · Sep 30, 2023 $18.73M
Total Assets Q3 2023 · Dec 31, 2022 $19.49M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.13
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.35
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.18
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.50
Eps Basic Q3 2023 · Sep 30, 2023 −$0.13
Eps Basic Q3 2023 · Sep 30, 2023 −$0.35
Eps Basic Q3 2023 · Sep 30, 2022 −$0.18
Eps Basic Q3 2023 · Sep 30, 2022 −$0.50
Sga Expense Q3 2023 · Sep 30, 2023 $276.73K
Sga Expense Q3 2023 · Sep 30, 2023 $669.35K
Sga Expense Q3 2023 · Sep 30, 2022 $261.51K
Sga Expense Q3 2023 · Sep 30, 2022 $926.74K
Net Income Q3 2023 · Sep 30, 2023 −$2.15M
Net Income Q3 2023 · Sep 30, 2023 −$5.81M
Net Income Q3 2023 · Sep 30, 2022 −$2.69M
Net Income Q3 2023 · Sep 30, 2022 −$7.44M
Operating Income Q3 2023 · Sep 30, 2023 −$1.41M
Operating Income Q3 2023 · Sep 30, 2023 −$3.78M
Operating Income Q3 2023 · Sep 30, 2022 −$1.39M
Operating Income Q3 2023 · Sep 30, 2022 −$4.28M
Gross Profit Q3 2023 · Sep 30, 2023 $146.62K
Gross Profit Q3 2023 · Sep 30, 2023 $575.04K
Gross Profit Q3 2023 · Sep 30, 2022 $47.33K
Gross Profit Q3 2023 · Sep 30, 2022 $285.68K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $201.23K
Cost Of Revenue Q3 2023 · Sep 30, 2023 $849.42K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $318.92K
Cost Of Revenue Q3 2023 · Sep 30, 2022 $1.02M
Revenue Q3 2023 · Sep 30, 2023 $347.85K
Revenue Q3 2023 · Sep 30, 2023 $1.42M
Revenue Q3 2023 · Sep 30, 2022 $366.24K
Revenue Q3 2023 · Sep 30, 2022 $1.3M
Capex Q3 2023 · Sep 30, 2022 $144.96K